Reported Aug 26, 2015 · Terminated

Lisinopril Tablets USP, 5 mg, 1000-count bottles, Rx Only, Manufactured by: Wockhardt Limited, Mumbai, India;…

Wockhardt USA Inc.

Moderate riskThis product could cause temporary or reversible health problems — stop using it.

What you should do

Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.

Firm contact: Wockhardt Usa Inc. · 20 Waterview Blvd Ste 3 · Parsippany, NJ · 07054-1271

Is this the product you have?

  • Lisinopril Tablets USP, 5 mg, 1000-count bottles, Rx Only
  • Manufactured byWockhardt Limited, Mumbai, India
  • Distributed by
    • Wockhardt USA LLC
    • 20 Waterview Blvd
    • Parsippany
    • NJ 07054 USA
    • UPC 3 64679 92806 6
    • NDC 64679-928-06
Lot codes and dates
    • Lot #: DM12700
    • Exp 09/15
Amount recalled
1704 bottles

This recall covers 2 products

The agency filed one notice per product. You are reading one of them; the other one is below.

Where it was sold

  • Nationwide

Why it was recalled

CGMP Deviations: An FDA inspection identified inadequate investigations of past market complaints.

This product could cause temporary or reversible health problems — stop using it.

Want the full recall guide?

The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.

Free recall alerts

Get alerted about new Wockhardt USA Inc. recalls

One email when a matching recall is published. No account, no cost, unsubscribe in one click.

Where this came from

Source: U.S. Food & Drug Administration (openFDA)

Read the FDA (openFDA drug enforcement) notice

Notice updated Apr 12, 2017 · Data as of Sep 19, 6:33 PM UTC

RecallNow is not a government agency. Every fact on this page is published by the FDA, USDA or CPSC and links back to their notice.